Using transdermal estrogen to treat bone loss in women with anorexia nervosa
Transdermal estrogen for the treatment of bone loss in women with anorexia nervosa
This study is looking at how a skin patch with estrogen might help women with anorexia nervosa who are experiencing serious bone loss, aiming to find a safe and effective way to strengthen their bones even after they’ve gained weight.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pittsburgh at Pittsburgh NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project ID | NIH-10661574 on NIH RePORTER |
What this research studies
This research investigates the use of transdermal estrogen as a treatment for severe bone loss in women suffering from anorexia nervosa. Anorexia nervosa can lead to significant bone density loss, increasing the risk of fractures, even after weight recovery. The study aims to provide a long-term solution to this issue, as current treatments have limitations and potential harmful effects. By focusing on the hormonal imbalances caused by the disorder, the research seeks to improve bone health in affected individuals.
Who could benefit from this research
Good fit: Ideal candidates for this research are women diagnosed with anorexia nervosa who are experiencing significant bone loss.
Not a fit: Patients who do not have anorexia nervosa or those who are not experiencing bone loss may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide a safe and effective long-term treatment option to prevent bone loss in women with anorexia nervosa.
How similar studies have performed: Previous research has shown some success with other treatments for bone loss in anorexia nervosa, but this approach using transdermal estrogen is relatively novel.
Where this research is happening
Pittsburgh, United States
- University of Pittsburgh at Pittsburgh — Pittsburgh, United States (Active)
Researchers
- Principal investigator: Fazeli, Pouneh Khadejeh — University of Pittsburgh at Pittsburgh
- Study coordinator: Fazeli, Pouneh Khadejeh
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.